Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Corporation (NASDAQ: RKLB) closed at a fresh all-time high on Friday, December 19, after landing its largest contract to date: a major U.S. Space Force-linked award to build missile-defense satellites for the Space Development Agency (SDA). The move capped off a volatile, news-packed stretch for the company—one that also included a high-profile U.S. Space Force launch completed months ahead of schedule, a first dedicated mission for Japan’s space agency, and continued drumbeat updates on Rocket Lab’s next-generation Neutron rocket program. SDA+3MarketWatch+3Investing.com+3 As of Saturday, December 20, 2025 (U.S. markets closed), the latest official close being digested by investors
20 December 2025
·
Ondas Holdings (ONDS) Stock Surges on Defense Robotics Momentum: Latest News, Forecasts, and Analyst Views (Dec. 20, 2025)

Ondas Holdings (ONDS) Stock Surges on Defense Robotics Momentum: Latest News, Forecasts, and Analyst Views (Dec. 20, 2025)

December 20, 2025 — Ondas Holdings Inc. (NASDAQ: ONDS) is back in the spotlight after a sharp, high-volume move to close Friday, December 19, 2025 at $9.22, up 18.21% in a single session. Trading volume also spiked to roughly 125 million shares, a “something big is happening” kind of number for a company of this size. Ondas Holdings Inc. The rally didn’t arrive out of nowhere. Over the past three weeks—especially in mid-December—Ondas has stacked a rapid sequence of defense-and-security-focused headlines: leadership expansion, acquisition integration, a European industrial cooperation push, counter-drone orders, and an AI-driven demining pilot with measurable real-world
20 December 2025
···
Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics, Inc. (Nasdaq: EWTX) is ending mid-December 2025 in classic clinical-stage biotech fashion: big percentage swings, a sharp momentum breakout, and investors trying to decide whether the move is “new information” or simply “new positioning.” As of Saturday, December 20, 2025, EWTX is being widely quoted around $25.55—a level reached after a powerful jump in the prior U.S. session. StockAnalysis+1 What matters for readers tracking the stock isn’t just the price print. It’s the why: a late-stage neuromuscular story (sevasemten), a closely watched cardiovascular program (EDG-7500), and a pipeline that can re-rate quickly on clinical updates—up or down. PR
20 December 2025
·
CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave, Inc. (NASDAQ: CRWV) has snapped back sharply after a bruising second half of 2025, with the AI infrastructure stock jumping about 22.5% in the latest session to around $83, after trading between roughly $70.70 and $84.19 on heavy volume. The move caps a week dominated by two storylines investors keep circling: validation (government and Wall Street endorsements) versus vulnerability (debt, dilution risk, and execution bottlenecks). Here’s what’s driving CoreWeave stock right now—and what matters most heading into 2026. Why CoreWeave stock jumped: Citi’s “Buy” (with a warning label) and the DOE Genesis Mission Citi resumes coverage: bullish rating, lower
20 December 2025
···
Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

December 20, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) is suddenly trading like a classic merger-arbitrage stock after BioMarin Pharmaceutical (NASDAQ: BMRN) agreed to acquire the company in an all-cash deal valued at roughly $4.8 billion. BioMarin’s offer of $14.50 per share sparked a sharp re-pricing of Amicus shares, which have been hovering just below the bid as investors weigh deal timing, closing risk, and what the buyout means for Amicus’ two commercial rare-disease franchises—Galafold (Fabry disease) and Pombiliti + Opfolda (Pompe disease). SEC+1 Below is a detailed breakdown of the latest news (as of 20.12.2025), plus the most relevant
20 December 2025
·····
DJT Stock News Today: Trump Media & Technology Group Jumps on $6B TAE Fusion Merger—Price, Forecasts, and Key Risks (Dec. 20, 2025)

DJT Stock News Today: Trump Media & Technology Group Jumps on $6B TAE Fusion Merger—Price, Forecasts, and Key Risks (Dec. 20, 2025)

Dec. 20, 2025 — Trump Media & Technology Group Corp. (NASDAQ: DJT) is back in the spotlight after announcing a surprise all-stock merger with nuclear fusion company TAE Technologies—a deal the companies describe as valued at more than $6 billion and aimed at accelerating the buildout of a utility-scale fusion power plant. GlobeNewswire+1 The announcement sparked a sharp rally in DJT stock, which surged more than 40% on Dec. 18 and remained highly active as traders repositioned around what many see as a dramatic pivot: from a money-losing social media business to a long-dated, high-uncertainty bet on the future of
20 December 2025
··
Firefly Aerospace Stock (NASDAQ: FLY) News Today — Dec. 20, 2025: Why Shares Jumped, Analyst Forecasts, SEC Filings, and the Lawsuit Clock

Firefly Aerospace Stock (NASDAQ: FLY) News Today — Dec. 20, 2025: Why Shares Jumped, Analyst Forecasts, SEC Filings, and the Lawsuit Clock

Firefly Aerospace Inc. (NASDAQ: FLY) is back in the spotlight as of Saturday, December 20, 2025—not because markets are open today (they aren’t), but because Friday’s session (Dec. 19) delivered the kind of price action that turns a newly public space company into weekend reading. FLY stock surged 22.82% on Dec. 19 to close at $24.65, after climbing 8.31% the day before. StockAnalysis+1 That two-day jump is now colliding with a dense stack of “investor attention catalysts”: a fresh analyst initiation, updated Wall Street price targets, a resale registration tied to the SciTec acquisition, and a still-active securities lawsuit timeline.
20 December 2025
·
Saudi Stock Exchange (Tadawul) Update on 20 Dec 2025: TASI Rebounds From Two‑Year Low as Oil, Rate Cuts and IPO Sentiment Shape 2026

Saudi Stock Exchange (Tadawul) Update on 20 Dec 2025: TASI Rebounds From Two‑Year Low as Oil, Rate Cuts and IPO Sentiment Shape 2026

As Saudi Arabia heads into the final stretch of 2025, the Saudi Stock Exchange (Tadawul) is finishing the year in a tense, valuation-sensitive mood—caught between supportive domestic monetary conditions and stubborn external headwinds led by oil-market weakness. Because Saturday, 20 December 2025 is a weekend in Saudi Arabia (Tadawul’s main market typically trades Sunday–Thursday), the most recent price signal comes from Thursday’s close (18 December)—when the Tadawul All Share Index (TASI) ended at 10,450.27, up 0.35% on the day. Arab News+1 That close matters because it followed a rough patch: TASI closed at 10,414.06 on 17 December, described by Reuters
20 December 2025
Mexico Stock Exchange News (Dec. 20, 2025): BMV Holds Near 64,000 as Banxico Cuts to 7%, Volaris-Viva Merger Sparks Rally, and 2026 IPC Forecasts Firm Up

Mexico Stock Exchange News (Dec. 20, 2025): BMV Holds Near 64,000 as Banxico Cuts to 7%, Volaris-Viva Merger Sparks Rally, and 2026 IPC Forecasts Firm Up

MEXICO CITY — December 20, 2025. The Mexico Stock Exchange (Bolsa Mexicana de Valores, BMV) heads into the final stretch of the year with a classic emerging-market cocktail: a still-strong 2025 rally, a choppy December tape, and a growing debate over whether cheaper money (thanks to Banxico) will keep lifting equities—or whether inflation shocks and trade risks will force a pause that cools the party. With Mexican markets closed on Saturday, the freshest “today” snapshot is Friday’s close. Mexico’s benchmark equity gauge—the S&P/BMV IPC, which tracks the largest and most liquid stocks listed on the BMV—ended the week hovering around
20 December 2025
·
São Paulo Stock Exchange (B3) Outlook: Ibovespa Near 158,000 After Brazil’s 2026 Budget Approval as Selic Rate-Cut Bets and Election Politics Drive 2026 Forecasts

São Paulo Stock Exchange (B3) Outlook: Ibovespa Near 158,000 After Brazil’s 2026 Budget Approval as Selic Rate-Cut Bets and Election Politics Drive 2026 Forecasts

São Paulo — December 20, 2025. Brazil’s stock market is heading into the year-end slowdown with a familiar mix of ingredients: a powerful 2025 rally still visible in the rear-view mirror, a short-term volatility hangover from politics, and a 2026 narrative increasingly dominated by one question—when does the Selic finally start coming down? TradingView+2Reuters+2 On Friday (Dec. 19), the Ibovespa—the benchmark index for the São Paulo Stock Exchange, B3—closed higher for a second consecutive session, ending at 158,473.02 points after touching 159,551.94 intraday. But the broader tone was not “all-clear”: the index still finished the week down about 1.4%, while
20 December 2025
Johannesburg Stock Exchange (JSE) Update: All Share at 114,850, ETFs Near R250bn, and the 2026 Outlook (as of 20 Dec 2025)

Johannesburg Stock Exchange (JSE) Update: All Share at 114,850, ETFs Near R250bn, and the 2026 Outlook (as of 20 Dec 2025)

JOHANNESBURG — The Johannesburg Stock Exchange (JSE) is heading into the year-end stretch with South African equities hovering near record territory, while the exchange’s product mix continues to evolve rapidly—especially through exchange-traded funds (ETFs) and new listings tied to telecoms and technology. With South Africa’s markets closed for the weekend, the latest official print shows the FTSE/JSE All Share at 114,850 and the Top 40 at 107,215 (both recorded at 19 December 2025, 17:05). JSE That level puts the benchmark within striking distance of its recent highs: the Financial Times’ markets data page lists a 52‑week range topping out at
20 December 2025
SIX Swiss Exchange Update (Dec. 20, 2025): SMI Near 13,200 as Trading Hits CHF 1 Trillion, EuroCTP Tape Chosen, and 2026 Outlook Takes Shape

SIX Swiss Exchange Update (Dec. 20, 2025): SMI Near 13,200 as Trading Hits CHF 1 Trillion, EuroCTP Tape Chosen, and 2026 Outlook Takes Shape

Zurich — Dec. 20, 2025. Swiss markets are paused for the weekend, but the Swiss Exchange story is still moving. The most recent session (Friday, Dec. 19) left the Swiss Market Index (SMI) hovering just shy of the 13,200 area, while the market digested a busy December mix of exchange milestones (turnover and ETF listings), big regulatory plumbing news (Europe’s consolidated tape decision), and a macro backdrop defined by a zero-rate Swiss National Bank and softer—but still positive—growth forecasts for 2026. ESMA+4Nasdaq+4Trading Economics+4 At the center sits SIX Swiss Exchange, the core trading venue in Switzerland and part of the
20 December 2025
1 … 598 599 600 601 602 … 890

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop